Methods and Compositions for In Vitro and In Vivo Chondrogenesis
AssigneeBioTime, Inc.
InventorsMichael West, Hal Sternberg, Karen Chapman
Life of this patent
Estimating the term…
Abstract
Aspects of the present invention include methods and compositions related to the production, identification and use of embryonic progenitor cell lines that are capable of undergoing chondrogenesis. A number of exemplary chondrogenic cell lines derived from primordial stem cells are disclosed. The chondrogenic cell lines described herein are robust, can expand for >40 passages, and have site-specific purity, thus providing for compositions and methods of producing diverse cartilage types with unique molecular compositions for use in research and therapy.
Claims17
1-30. (canceled)
A clonal progenitor cell line that expresses the genes COL2A, SOX9, and ENG, but does not express at least one of the genes chosen from CD74, ITGA2, and KCNK2.
The clonal progenitor cell line of 42, wherein the carrier is a scaffold.
The clonal progenitor cell line of 42, wherein the carrier is a matrix.
A method of producing cartilage comprising culturing the clonal progenitor cell line of claim 1 under cartilage producing conditions.
Dependencies are inferred from the claim text.